Animal Model Market in USA: Leading at 7.1% CAGR Through 2035 | Fact.MR

The global animal model market is projected to expand from USD 2.8 billion in 2025 to approximately USD 5.1 billion by 2035, representing a compound annual growth rate (CAGR) of about 6.2%. Growth is driven by the increasing demand for reliable pre-clinical models in drug discovery, growing biotechnology and academic research, and rising adoption of genetically engineered animal models.

As pharmaceutical companies and research institutions intensify efforts to develop targeted therapies, precision medicine platforms, and biologics, the need for advanced, disease-relevant animal models becomes essential. This demand is increasingly being met by innovative breeding services, advanced genetic engineering, and integrated research provider offerings.

Key Market Insights at a Glance

• Market Value (2025): USD 2.8 billion
• Forecast Value (2035): USD 5.1 billion
• CAGR (2025–2035): ~6.2%
• Leading Species Segment (2025): Mice (~52% share)
• Dominant Application Segment (2025): Oncology (~41% share)
• Key Growth Regions: North America, Europe, Asia-Pacific
• Prominent Players: The Jackson Laboratory, Charles River Laboratories, Envigo, Taconic Biosciences, GemPharmatech, InVivos

To Access the Complete Data Tables & in-depth Insights, Request a Discount on this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=1590

Market Drivers / Growth Overview

Several key factors underpin the animal model market growth:

• Expansion of pharmaceutical & biotech pipelines: Rising drug discovery and development activities across oncology, CNS/metabolic disorders and immunology are driving demand for sophisticated animal models.
• Advances in genetic engineering & precision breeding: Innovations in CRISPR, humanized models, and disease-specific animal lines are enabling more predictive pre-clinical research outcomes.
• Growth in biotechnology research and academic demand: As research funding and infrastructure expand globally, universities and CROs require reliable animal models to support translational science.
• Outsourcing to research service providers: Contract research organisations (CROs) and integrated modelling service providers are scaling breeding and custom model services to meet demand, enhancing accessibility.
• Regional expansion of research capabilities: Emerging markets in Asia-Pacific and Latin America are building up pre-clinical research infrastructure, contributing to global volume growth.

However, the market also faces restraints such as ethical concerns, regulatory complexity, and alternative model technologies (in-vitro, in-silico) which may moderate growth.

Segmentation & Key Drivers

By Species:

• Mice lead the market (~52% share in 2025) due to their genetic tractability, well-established protocols and broad researcher familiarity.
• Rats and zebrafish/other species follow, with growth driven by specific disease models and cost-efficiency.

By Application:

• Oncology holds the largest application share (~41% in 2025) as cancer drug discovery dominates pre-clinical demand.
• CNS/metabolic disorders reflect growing therapeutic focus and increasing research investment.
• Other research areas include immunology, infectious diseases and regenerative medicine.

By Service Type:

• Breeding services account for a significant share (~46% in 2025) as foundational model supply.
• CRO study services and custom/other services grow where demand for tailored models and integrated study execution increases.

Segmentation drivers include species suitability for application, customisation needs, regulatory requirements, and provider service breadth.

Regional & Country Insights

• North America: Leads the market with strong pharmaceutical R&D, advanced genetic modelling technologies and extensive research infrastructure.
• Europe: A mature market with established animal model supply chains, rigorous research standards and strong demand for disease-relevant models.
• Asia-Pacific: Fastest growth region as biotech investments increase, research capacity expands and domestic animal model services mature.
• Latin America & Middle East/Africa: Emerging markets with incremental opportunity as research infrastructure and regulatory frameworks improve.

Regional growth reflects research investment, model-provider availability, regulatory clarity and disease-research focus.

Competitive Landscape

The animal model market is moderately competitive, with key global players dominating supply and service channels. Notable companies include The Jackson Laboratory, Charles River Laboratories, Envigo, Taconic Biosciences, GemPharmatech and InVivos.

Strategic focus areas for providers include: expanding breeding and custom model capabilities, developing disease-specific and genetically engineered lines, establishing global service networks (especially in high-growth regions), and partnering with pharmaceutical and academic customers for tailored solutions.

Market Outlook & Strategic Insights

Over the forecast period through 2035, the animal model market is expected to transition from standard model supply toward value-added services, integrated research platforms and customized disease-models. Strategic imperatives for market participants include:

• Investing in genetic engineering capabilities and model portfolios targeting high growth applications like oncology and CNS disorders.
• Expanding global service footprints, particularly in emerging markets, to capture regional growth and support local research initiatives.
• Offering integrated research services (breeding + custom model + study execution) to provide end-to-end solutions for pharmaceutical customers.
• Monitoring regulatory and ethical trends, as increasing scrutiny of animal research demands providers maintain high welfare, compliance and alternative-model capabilities.
• Differentiating through custom model development and high-throughput capability to meet pharmaceutical expectations for translational relevance and speed.

Companies that execute these strategic actions—while maintaining model quality, research reliability and regulatory compliance—will be well-positioned to capture meaningful share in a market projected to exceed USD 5.1 billion by 2035.

Purchase Full Report for Detailed Insights:

For access to full forecasts, regional breakouts, company share analysis, and emerging trend assessments, you can purchase the complete report: https://www.factmr.com/checkout/1590

Have specific requirements and need assistance on report pricing or have a limited budget? Please contact sales@factmr.com

Related Reports:

Animal Genetics Market

Animal Parasiticides Market

Animal Probiotic Market

Animal Antibiotics Market

About Fact.MR:

Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.